Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Article too big to display. Click here to view on the SEC website

Genmab AS (NASDAQ:GMAB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Click aqui para mais gráficos Genmab AS.

Genmab AS (NASDAQ:GMAB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025

Click aqui para mais gráficos Genmab AS.

Notícias Genmab AS

Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Segunda, 9 de Dezembro de 2024 (4 semanas atrás) • Business Wire

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis
Domingo, 8 de Dezembro de 2024 (4 semanas atrás) • Business Wire

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Sábado, 7 de Dezembro de 2024 (4 semanas atrás) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 4 de Dezembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 3 de Dezembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 3 de Dezembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 27 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 21 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting
Terça, 5 de Novembro de 2024 (2 meses atrás) • Business Wire

Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial
Domingo, 15 de Setembro de 2024 (4 meses atrás) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 11 de Setembro de 2024 (4 meses atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 10 de Setembro de 2024 (4 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Genmab AS

Índice Bovespa

PÃO DE AÇUCAR ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições